Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Vortioxetine Differentially Modulates MK-801-Induced Changes in Visual Signal Detection Task Performance and Locomotor Activity.

Hillhouse TM, Merritt CR, Smith DA, Cajina M, Sanchez C, Porter JH, Pehrson AL.

Front Pharmacol. 2018 Sep 13;9:1024. doi: 10.3389/fphar.2018.01024. eCollection 2018.

2.

Drug Discrimination: Historical Origins, Important Concepts, and Principles.

Porter JH, Prus AJ, Overton DA.

Curr Top Behav Neurosci. 2018;39:3-26. doi: 10.1007/7854_2018_40.

PMID:
29637526
3.

Concept Test of a Smoking Cessation Smart Case.

Comello MLG, Porter JH.

Telemed J E Health. 2018 Apr 5. doi: 10.1089/tmj.2017.0196. [Epub ahead of print]

PMID:
29621000
4.

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice.

Manvich DF, Webster KA, Foster SL, Farrell MS, Ritchie JC, Porter JH, Weinshenker D.

Sci Rep. 2018 Mar 1;8(1):3840. doi: 10.1038/s41598-018-22116-z.

5.

Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice.

Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH.

Psychopharmacology (Berl). 2017 Dec;234(23-24):3507-3520. doi: 10.1007/s00213-017-4738-y. Epub 2017 Sep 18.

PMID:
28921163
6.

Seagrass blue carbon spatial patterns at the meadow-scale.

Oreska MPJ, McGlathery KJ, Porter JH.

PLoS One. 2017 Apr 27;12(4):e0176630. doi: 10.1371/journal.pone.0176630. eCollection 2017.

7.

Translational Value of Drug Discrimination with Typical and Atypical Antipsychotic Drugs.

Porter JH, Webster KA, Prus AJ.

Curr Top Behav Neurosci. 2018;39:193-212. doi: 10.1007/7854_2017_4.

PMID:
28341945
8.

Discriminative stimulus properties of 1.25mg/kg clozapine in rats: Mediation by serotonin 5-HT2 and dopamine D4 receptors.

Prus AJ, Wise LE, Pehrson AL, Philibin SD, Bang-Andersen B, Arnt J, Porter JH.

Brain Res. 2016 Oct 1;1648(Pt A):298-305. doi: 10.1016/j.brainres.2016.08.004. Epub 2016 Aug 5.

PMID:
27502027
9.

Task- and Treatment Length-Dependent Effects of Vortioxetine on Scopolamine-Induced Cognitive Dysfunction and Hippocampal Extracellular Acetylcholine in Rats.

Pehrson AL, Hillhouse TM, Haddjeri N, Rovera R, Porter JH, Mørk A, Smagin G, Song D, Budac D, Cajina M, Sanchez C.

J Pharmacol Exp Ther. 2016 Sep;358(3):472-82. doi: 10.1124/jpet.116.233924. Epub 2016 Jul 11.

10.

The Discriminative Stimulus Properties of Drugs Used to Treat Depression and Anxiety.

Prus AJ, Porter JH.

Curr Top Behav Neurosci. 2018;39:213-241. doi: 10.1007/7854_2016_27.

PMID:
27352389
11.

In Vitro and In Vivo Characterization of the Alkaloid Nuciferine.

Farrell MS, McCorvy JD, Huang XP, Urban DJ, White KL, Giguere PM, Doak AK, Bernstein AI, Stout KA, Park SM, Rodriguiz RM, Gray BW, Hyatt WS, Norwood AP, Webster KA, Gannon BM, Miller GW, Porter JH, Shoichet BK, Fantegrossi WE, Wetsel WC, Roth BL.

PLoS One. 2016 Mar 10;11(3):e0150602. doi: 10.1371/journal.pone.0150602. eCollection 2016.

12.

Validation of Biomarkers of CVD Risk from Dried Blood Spots in Community-Based Research: Methodologies and Study-Specific Serum Equivalencies.

Samuelsson LB, Hall MH, McLean S, Porter JH, Berkman L, Marino M, Sembajwe G, McDade TW, Buxton OM.

Biodemography Soc Biol. 2015;61(3):285-97. doi: 10.1080/19485565.2015.1068105.

13.

Effects of the noncompetitive N-methyl-D-aspartate receptor antagonist ketamine on visual signal detection performance in rats.

Hillhouse TM, Merritt CR, Porter JH.

Behav Pharmacol. 2015 Aug;26(5):495-9. doi: 10.1097/FBP.0000000000000160.

14.

The antidepressant drugs fluoxetine and duloxetine produce anxiolytic-like effects in a schedule-induced polydipsia paradigm in rats: enhancement of fluoxetine's effects by the α2 adrenoceptor antagonist yohimbine.

Prus AJ, Mooney-Leber SM, Berquist MD 2nd, Pehrson AL, Porter NP, Porter JH.

Behav Pharmacol. 2015 Aug;26(5):489-94. doi: 10.1097/FBP.0000000000000159.

PMID:
26154437
15.

A brief history of the development of antidepressant drugs: from monoamines to glutamate.

Hillhouse TM, Porter JH.

Exp Clin Psychopharmacol. 2015 Feb;23(1):1-21. doi: 10.1037/a0038550. Review.

16.

Comparison of antidepressant-like and abuse-related effects of phencyclidine in rats.

Hillhouse TM, Porter JH, Negus SS.

Drug Dev Res. 2014 Dec;75(8):479-88. doi: 10.1002/ddr.21228. Epub 2014 Oct 15.

17.

Work stress, sleep deficiency, and predicted 10-year cardiometabolic risk in a female patient care worker population.

Jacobsen HB, Reme SE, Sembajwe G, Hopcia K, Stiles TC, Sorensen G, Porter JH, Marino M, Buxton OM.

Am J Ind Med. 2014 Aug;57(8):940-9. doi: 10.1002/ajim.22340. Epub 2014 May 8. Erratum in: Am J Ind Med. 2015 Jan;58(1):112.

18.

(S)-amisulpride as a discriminative stimulus in C57BL/6 mice and its comparison to the stimulus effects of typical and atypical antipsychotics.

Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH.

Eur J Pharmacol. 2014 Jul 5;734:15-22. doi: 10.1016/j.ejphar.2014.03.047. Epub 2014 Apr 12.

PMID:
24726559
19.

Reply to: Rapid antidepressant effects and abuse liability of ketamine.

Hillhouse TM, Porter JH, Negus SS.

Psychopharmacology (Berl). 2014 May;231(9):2043-4. No abstract available.

20.

Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats.

Hillhouse TM, Porter JH, Negus SS.

Psychopharmacology (Berl). 2014 Jul;231(13):2705-16. doi: 10.1007/s00213-014-3451-3. Epub 2014 Feb 13.

21.

Dried blood spot collection of health biomarkers to maximize participation in population studies.

Ostler MW, Porter JH, Buxton OM.

J Vis Exp. 2014 Jan 28;(83):e50973. doi: 10.3791/50973.

22.

Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.

Hillhouse TM, Porter JH.

Behav Pharmacol. 2014 Feb;25(1):80-91. doi: 10.1097/FBP.0000000000000014.

PMID:
24370559
23.

Thr136Ile polymorphism of human vesicular monoamine transporter-1 (SLC18A1 gene) influences its transport activity in vitro.

Khalifa AM, Watson-Siriboe A, Shukry SG, Chiu WL, Nelson ME, Geng Y, Fischer-Stenger K, Porter JH, Stewart JK.

Neuro Endocrinol Lett. 2012;33(5):546-51.

PMID:
23090274
24.

Relationship of sleep deficiency to perceived pain and functional limitations in hospital patient care workers.

Buxton OM, Hopcia K, Sembajwe G, Porter JH, Dennerlein JT, Kenwood C, Stoddard AM, Hashimoto D, Sorensen G.

J Occup Environ Med. 2012 Jul;54(7):851-8. doi: 10.1097/JOM.0b013e31824e6913.

25.

Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 mice.

Wiebelhaus JM, Vunck SA, Meltzer HY, Porter JH.

Behav Pharmacol. 2012 Jun;23(3):262-70. doi: 10.1097/FBP.0b013e3283534332.

PMID:
22547022
26.

Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption.

Buxton OM, Cain SW, O'Connor SP, Porter JH, Duffy JF, Wang W, Czeisler CA, Shea SA.

Sci Transl Med. 2012 Apr 11;4(129):129ra43. doi: 10.1126/scitranslmed.3003200.

27.

Staying afloat in the sensor data deluge.

Porter JH, Hanson PC, Lin CC.

Trends Ecol Evol. 2012 Feb;27(2):121-9. doi: 10.1016/j.tree.2011.11.009. Epub 2011 Dec 27. Review.

PMID:
22206661
28.

Activity-based metagenomic screening and biochemical characterization of bovine ruminal protozoan glycoside hydrolases.

Findley SD, Mormile MR, Sommer-Hurley A, Zhang XC, Tipton P, Arnett K, Porter JH, Kerley M, Stacey G.

Appl Environ Microbiol. 2011 Nov;77(22):8106-13. doi: 10.1128/AEM.05925-11. Epub 2011 Sep 23.

29.

[Thirty years of US long-term ecological research: characteristics, results, and lessons learned of--taking the Virginia Coast Reserve as an example].

Zhu GR, Porter JH, Xu XG.

Ying Yong Sheng Tai Xue Bao. 2011 Jun;22(6):1615-22. Review. Chinese.

PMID:
21941767
30.

The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 mice.

Wiebelhaus JM, Webster KA, Meltzer HY, Porter JH.

Behav Pharmacol. 2011 Sep;22(5-6):458-67. doi: 10.1097/FBP.0b013e328348ec4f.

PMID:
21712711
31.
32.

Clozapine and N-methyl-D-aspartate have positive modulatory actions on their respective discriminative stimulus properties in C57BL/6 mice.

Vunck SA, Wiebelhaus JM, Arnt J, Porter JH.

Eur J Pharmacol. 2011 Jan 15;650(2-3):579-85. doi: 10.1016/j.ejphar.2010.10.022. Epub 2010 Oct 20.

PMID:
20969851
33.

Effects of lexical status and morphological complexity in masked priming: An ERP study.

Morris J, Porter JH, Grainger J, Holcomb PJ.

Lang Cogn Process. 2010 May 1;26(4-6):558-599.

34.

Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle.

Vann RE, Wise LE, Varvel SA, Philibin SD, Walentiny DM, Porter JH.

Drug Alcohol Depend. 2009 Aug 1;103(3):124-30. doi: 10.1016/j.drugalcdep.2009.02.015. Epub 2009 May 14.

35.

Drug discrimination: 30 years of progress.

Porter JH, Prus AJ.

Psychopharmacology (Berl). 2009 Apr;203(2):189-91. doi: 10.1007/s00213-009-1478-7. Epub 2009 Feb 19. No abstract available.

PMID:
19225764
36.

Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism.

Philibin SD, Walentiny DM, Vunck SA, Prus AJ, Meltzer HY, Porter JH.

Psychopharmacology (Berl). 2009 Apr;203(2):303-15. doi: 10.1007/s00213-008-1385-3. Epub 2008 Nov 7.

PMID:
18989659
37.

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG.

Pharmacol Rev. 2008 Sep;60(3):358-403. doi: 10.1124/pr.107.00107. Review. Erratum in: Pharmacol Rev. 2008 Dec;60(4):582.

38.

Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies.

Porter JH, Prus AJ.

Psychopharmacology (Berl). 2009 Apr;203(2):279-94. doi: 10.1007/s00213-008-1308-3. Epub 2008 Sep 16. Review.

PMID:
18795269
39.

A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice.

Porter JH, Walentiny DM, Philibin SD, Vunck SA, Crabbe JC.

Behav Pharmacol. 2008 Sep;19(5-6):530-42. doi: 10.1097/FBP.0b013e32830cd84e.

PMID:
18690107
40.

The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats.

Prus AJ, Pehrson AL, Philibin SD, Wood JT, Vunck SA, Porter JH.

Psychopharmacology (Berl). 2009 Apr;203(2):295-301. doi: 10.1007/s00213-008-1262-0. Epub 2008 Aug 7.

PMID:
18685832
41.

Aging is associated with myocardial insulin resistance and mitochondrial dysfunction.

Bhashyam S, Parikh P, Bolukoglu H, Shannon AH, Porter JH, Shen YT, Shannon RP.

Am J Physiol Heart Circ Physiol. 2007 Nov;293(5):H3063-71. Epub 2007 Sep 14.

42.

Fiber digestibility by black lemurs (Eulemur macaco macaco).

Schmidt DA, Kerley MS, Porton IJ, Porter JH, Dempsey JL, Griffin ME, Ellersieck MR, Sadler WC.

J Zoo Wildl Med. 2005 Jun;36(2):204-11.

PMID:
17323560
43.

Fiber digestibility by the orangutan (Pongo abelii): in vitro and in vivo.

Schmidt DA, Kerley MS, Dempsey JL, Porton IJ, Porter JH, Griffin ME, Ellersieck MR, Sadler WC.

J Zoo Wildl Med. 2005 Dec;36(4):571-80.

PMID:
17312712
44.
47.
48.

Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice.

Philibin SD, Prus AJ, Pehrson AL, Porter JH.

Psychopharmacology (Berl). 2005 Jun;180(1):49-56. Epub 2005 Feb 5.

49.
50.

Pre-harvest factors influencing the acid resistance of Escherichia coli and E. coli O157:H7.

Fu CJ, Porter JH, Felton EE, Lehmkuhler JW, Kerley MS.

J Anim Sci. 2003 Apr;81(4):1080-7.

PMID:
12723098

Supplemental Content

Loading ...
Support Center